Benjamine Liu, Formation Bio co-founder and CEO

With a $372M megaround, For­ma­tion Bio looks to in-li­cense 10+ drugs

While the bulk of AI-fo­cused biotechs try to dis­cov­er drugs and push the bound­aries of bi­ol­o­gy, Ben­jamine Liu would rather syn­the­size meet­ing min­utes than mol­e­cules …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.